Real-world experience of rIX-FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy - Results from IDEAL Part B

Affiliations

• ¹ Regional Reference Centre for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy.
• ² Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi, Haemophilia and Thrombosis Centre, and Università degli Studi di Milano, Milan, Italy.
• ³ Regional Reference Centre for Haemorrhagic Diseases, IRCCS Istituto Giannina Gaslini, Genova, Italy.
• ⁴ Haemophilia Regional Reference Centre, Haematology Unit, Policlinico "G. Rodolico" - S. Marco Hospital, Catania, Italy.
• ⁵ Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
• ⁶ Haemostasis and Thrombosis Unit, Haematology Department, San Bortolo Hospital, Vicenza, Italy.
• ⁷ Inherited Bleeding Disorders Unit, IRCCS AOUBO, Bologna, Italy.
• ⁸ Department of Health Sciences, University of Genoa, Genova, Italy.
• ⁹ Hippocrates Research, Genova, Italy.
• ¹⁰ CSL Behring, Milan, Italy.
• ¹¹ Centre for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy.